Subscribe
COVID-19 Miniseries Episode 48: Neutralizing Antibody Assay, Explained

Mayo Clinic Talks

COVID-19 Miniseries Episode 48: Neutralizing Antibody Assay, Explained

This episode is shared from Answers from the Lab and was originally published June 30, 2020. Guest: John R. Mills, Ph.D. Host: Bobbi S. Pritt, M.D. (@ParasiteGal) John Mills, Ph.D., is the co-director…
August 21, 2020
ADVERTISEMENT
Wise-Formerly Transferwise

COVID-19 Miniseries Episode 48: Neutralizing Antibody Assay, Explained

This episode is shared from Answers from the Lab and was originally published June 30, 2020. 

Guest: John R. Mills, Ph.D. 

Host: Bobbi S. Pritt, M.D. (@ParasiteGal

John Mills, Ph.D., is the co-director of the Neuroimmunology Laboratory at Mayo Clinic and the scientist who oversaw the development and validation of the new neutralizing antibody assay. Today he joins us to explain what the neutralizing antibody assay is, why it is different than other COVID-19 tests, and the science and innovation behind these efforts. 

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd 

ADVERTISEMENT
Wise-Formerly Transferwise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Making the World a Healthier Place with AI and Data Mary Claire Duch, President of W2O pure & Jonathan Woodring, EVP & GM of IPM.ai